Week Ending: 11 September 2026

Mexico MX Healthcare Industry

Medical Devices

For the week ending 11 September 2026, Medical Devices declined 4.44% with 0 advancing, 6 declining, and 3 unchanged constituents. The index is equal weighted and the constituent tape shows uncapped security returns.

Current architecture Unresolved

The Activity Lines, Trend Line and price acceptance remain genuinely mixed.

35 technical evidence
Index1591.46 1 week-4.44% Breadth0% Members9
Country 🇲🇽 Mexico · MX
Sector Healthcare
Universe country-listed
Price basis Adjusted weekly close

Trend architecture

Index, activity fan and structural anchors

Rolling 156-week evidence. Trend Signal points mark weeks when price, trend and the activity fan confirmed together.

Index Value Trend Line Fair Value Activity Lines Constructive architecture Transitional architecture Defensive architecture
Current architecture Unresolved 11 completed weeks in this state
Trend acceptance -4.0% Index versus Trend Line
Persistence 75% Negative regime, shorter trend repairing
Participation 0% 0 advancing, 6 declining

Investor positioning lens

Is the evidence ready for capital?

A rules-based technical classification using trend, breadth, persistence, relative strength and path quality.

Current posture Reduce exposure into strength

Counter-trend rallies may occur, but primary structure and persistence do not yet support adding risk.

35 technical evidence
out of 100
Evidence balance

Five-pillar map

Reduce
Trend
30
Breadth
21
Persistence
26
Relative
50
Risk quality
76
What supports the view
  • No major confirming factor has secured control.
What restrains conviction
  • Index trend architecture has not delivered a durable upward expansion.
  • Breadth remains too narrow or inconsistent for a high-conviction position.
  • Constituent persistence remains divided or predominantly negative.
  • The group is not yet delivering dependable relative outperformance.
  • Stage 4 declining constituents exceed Stage 2 advancing constituents by 50 percentage points.
Independent sentiment overlay News tone is balanced

Sentiment is not supplying a meaningful directional edge.

Evidence that would change the view
  1. A completed weekly reclaim of 1,795.07, the higher of Trend Line and Fair Value, would improve the structural case.
  2. Breadth holding above 55% for several completed weeks would show that repair is spreading.
  3. Positive 13 and 26-week relative performance would confirm that capital is rotating into the group.

This is a weekly research classification, not personal investment advice. Sentiment is reported as an independent confirmation layer and does not alter the technical score.

Trend state and durability

Architecture, persistence and constituent regimes

The index path is tested against the underlying security-level trend evidence.

Index architecture Unresolved

The Activity Lines, Trend Line and price acceptance remain genuinely mixed.

State age11 weeks
Trend gateDown
Fan width2.87%
Fast versus slow change0.99 pts
Above 50% Below 17%
Six completed weeks of price acceptance relative to the full Activity Line fan.
Index persistence

Negative regime, shorter trend repairing

75% agreement

The long trend remains negative, but shorter-horizon repair is now visible.

13-week
5.9%
26-week
-13.6%
39-week
-23.1%
52-week
-22.2%
Regime age36 weeks 52-week flips3 52-week boundary2046.37
Constituent trend persistence

Is the index move broadly durable?

100% coverage
Coherent positive11%
Coherent negative33%
Average horizon agreement83%
Positive horizon share28%
Weakening positives0
Repairing negatives4

9 constituents measured as of 11 Sep 2026. Median trend age is 35 weeks.

Custom stage map

Where constituents sit in the cycle

89% coverage
Stage 1 · Basing25%2 securities
Stage 2 · Advancing13%1 securities
Stage 3 · Distribution0%0 securities
Stage 4 · Declining63%5 securities
Re-acceleration watch0 Transition watch0 Relative strength leaders12% Fair Value repairs2

Measured as of 11 Sep 2026. Stages summarize price, Activity Line architecture, Fair Value position and relative evidence.

Architecture breadth

How market energy is distributed

76/100 mean confidence
Upward expansion
12% 1
Rotation up
38% 3
Deceleration
0% 0
Balance
0% 0
Rotation down
0% 0
Downward expansion
50% 4
Unresolved
0% 0

Architecture breadth shows the distribution of expanding, rotating, balancing and contracting securities. It is diagnostic context and is not added as a second vote in the positioning score.

Capital rotation

Performance relative to Healthcare

Weakening
Relative index 13-week relative trend Starting level
Rotation dashboard Weakening

A rising relative line means this group is compounding faster than Healthcare. A falling line means capital has done better in the parent benchmark.

Relative index101.3
13-week trend102.9
4-week trend change0.36%
Weekly peer rank9 of 9
1 week
-2.1 pts relative
4 weeks
-6.8 pts relative
13 weeks
-0.9 pts relative
26 weeks
-17.0 pts relative
52 weeks
-27.0 pts relative

Market internals

Participation, dispersion and path risk

Equal-weight index evidence with constituent-level breadth and dispersion.

Breadth

Participation quality

Narrow
Advancing
0
Declining
6
Unchanged
3
4-week average 17%
13-week average 43%
Risk and persistence

Path quality

52-week lens
Annualised weekly volatility15.8%
Drawdown from 52-week high-24.2%
Positive weeks, last 1362%
Current directional run3 weeks
Turnover versus 13-week norm120%
Breadth impulse-46.3 pts
Cross-section

Return distribution

9 measured
Q1 -8.3% Median -1.3% Q3 0.0%
Average winner%
Average loser-6.7%
Dispersion5.0 pts
Top-five upside sharen/a
Top-five capital share91%
Capital data coverage100%

Dispersion describes how far constituent outcomes are spreading apart. Capital concentration is contextual only; the index itself is equal weighted.

Momentum cycle

30-week persistence

Positive readings show expansion. Negative readings show contraction.

Breadth cycle

Net participation

Advancers less decliners as a percentage of measured constituents.

News and narrative

Does company news confirm the market tape?

Open Sentiment Intelligence
Qualified weighted tone
52out of 100

Mixed

Positive and negative company-news scores are balancing each other.

Evidence quality

Coverage before conviction

38/100 confidence
Qualified companies333% of measured constituents
Articles129100% direct company evidence
Publishers26Independent sources represented
Latest evidence14 SepFreshness is weighted in the score
Constructive 33%Balanced 33%Cautious 33%
Price confirms news1
Price disagrees1
Negative news absorbed0
Positive but stretched0

Only fresh, quality-controlled company evidence is included. Industry and sector context is down-weighted and cannot create a directional group conclusion on its own.

Leadership tape

Leaders, laggards and contribution shape

Latest completed week, ranked on uncapped constituent returns.

Leading edge

1 DXCMDexCom, Inc.
0.00% 2 GMEDGlobus Medical, Inc.
0.00% 3 PODDInsulet Corporation
0.00% 4 MDTNMedtronic plc
-0.89% 5 TMDXTransMedics Group, Inc.
-1.34%

Weakest edge

9 SYKStryker Corporation
-14.34% 8 BSXBoston Scientific Corporation
-9.84% 7 GEHCGE HealthCare Technologies Inc.
-8.25% 6 ABTAbbott Laboratories
-5.32% 5 TMDXTransMedics Group, Inc.
-1.34%

Constituent ledger

Industry constituents

All 9 measured constituents, ranked by latest weekly return.

Rank Ticker Company Exchange Market cap Close Index contribution Return
1 DXCM DexCom, Inc. MEX 576.98B 1,529.00 0.00 pts
0.00%
2 GMED Globus Medical, Inc. MEX 186.68B 1,390.45 0.00 pts
0.00%
3 PODD Insulet Corporation MEX 173.67B 2,780.00 0.00 pts
0.00%
4 MDTN Medtronic plc MEX 2.00T 1,552.00 -0.10 pts
-0.89%
5 TMDX TransMedics Group, Inc. MEX 49.20B 1,400.00 -0.15 pts
-1.34%
6 ABT Abbott Laboratories MEX 3.26T 1,780.00 -0.59 pts
-5.32%
7 GEHC GE HealthCare Technologies Inc. MEX 542.02B 1,101.00 -0.92 pts
-8.25%
8 BSX Boston Scientific Corporation MEX 1.19T 728.50 -1.09 pts
-9.84%
9 SYK Stryker Corporation MEX 2.14T 4,770.00 -1.59 pts
-14.34%

The index uses capped equal-weight weekly constituent returns. The ledger shows uncapped security returns so outliers remain visible for research.

Evidence context